当前位置: 首页 > 期刊 > 《中国医药科学》 > 2012年第2期
编号:13184266
干扰素联合化疗治疗原发性肝癌50例疗效分析(2)
http://www.100md.com 2012年1月15日 《中国医药科学》 2012年第2期
     [2] Chen TM,Huang PT,Tsai MH,et al.Predictors of alpha-fetoprotein elevation in patients with chronic hepatitisC,but not hepatocellular carcinoma,and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy[J].J Gastroenterol Hepatol,2007,22(5):669-675.

    [3] Chawla-Sarkar M,Lindner DJ,Liu YF,et al.Apoptosis and interferons:role of interferon-stimulated genes as mediators of apoptosis[J].Apoptosis,2003,8(3):237.

    [4] Rashmi R,Kumar S,Karunagaran D.Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable wit h ectopic expression of Smac or downregulation of Bcl-xL[J]. Carcinogenesis,2005,26(4):713.

    [5] Yin H,Lee GI,Sedey KA,et al.Terphenyl-Based Bak BH3 alpha - helical proteomimetics as low-molecular -weight antagonists of Bcl-xL[J].J Am Chem Soc,2005,127(29):10191.

    [6] Tomimaru Y,Eguchi H,Nagano H,et al.MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells[J].2010,103(10):1617-1626.

    [7] Hu X,Chen W,Xu J.Downregulation of human equilibrative nucleoside transporter 1 by RNAi enhances 5-fluorouracil response in pancreatic cancer[J].Hepatogastroenterology,2010,57(104):1567-1572.

    (收稿日期:2011-12-23), 百拇医药(程春来 艾立清)
上一页1 2